TLX-031

N/A

Report date: 2023/12/15 17:52:40

Base Information

Drug NameTLX-031
Drug Alias NameAtomoxetine extended release (Tulex Pharmaceuticals)TLX-031
ClassificationSmall molecules
Mechanisms of ActionNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporter
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTulex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesTulex Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A